Literature DB >> 7734378

The high frequency of the -6G-->A factor IX promoter mutation is the result both of a founder effect and recurrent mutation at a CpG dinucleotide.

G E Morgan1, M S Figueiredo, P R Winship, R Baker, P H Bolton-Maggs, G G Brownlee.   

Abstract

We report a new Liverpool family with a mild haemophilia B Leyden phenotype caused by a -6G-->A mutation in a CpG dinucleotide in the promoter of the clotting factor IX gene. This mutation had previously been identified in three other U.K. pedigrees and six others worldwide. To investigate whether these mutations were of independent origin, the haplotype was determined for eight polymorphic loci, within or immediately adjacent to the factor IX gene, for nine of the 10 existing patients. Six probands had identical haplotypes, including all four U.K. probands, suggesting that they arose from a common founder. The other three probands differed in haplotype from the common haplotype, and from each other, suggesting that they were independent mutations at this CpG dinucleotide.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7734378     DOI: 10.1111/j.1365-2141.1995.tb08388.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

1.  Assessment of the F9 genotype-specific FIX inhibitor risks and characterisation of 10 novel severe F9 defects in the first molecular series of Argentinian patients with haemophilia B.

Authors:  Claudia Pamela Radic; Liliana Carmen Rossetti; Miguel Martín Abelleyro; Miguel Candela; Raúl Pérez Bianco; Miguel de Tezanos Pinto; Irene Beatriz Larripa; Anne Goodeve; Carlos Daniel De Brasi
Journal:  Thromb Haemost       Date:  2012-10-23       Impact factor: 5.249

2.  Haemophilia B (sixth edition): a database of point mutations and short additions and deletions.

Authors:  F Giannelli; P M Green; S S Sommer; M C Poon; M Ludwig; R Schwaab; P H Reitsma; M Goossens; A Yoshioka; G G Brownlee
Journal:  Nucleic Acids Res       Date:  1996-01-01       Impact factor: 16.971

Review 3.  Citrullinemia type I is associated with a novel splicing variant, c.773 + 4A > C, in ASS1: a case report and literature review.

Authors:  Yiming Lin; Hongzhi Gao; Bin Lu; Shuang Zhou; Tianwen Zheng; Weihua Lin; Lin Zhu; Mengyi Jiang; Qingliu Fu
Journal:  BMC Med Genet       Date:  2019-06-17       Impact factor: 2.103

4.  A CpG mutational hotspot in a ONECUT binding site accounts for the prevalent variant of hemophilia B Leyden.

Authors:  Alister P W Funnell; Michael D Wilson; Benoit Ballester; Ka Sin Mak; Jon Burdach; Natisha Magan; Richard C M Pearson; Frederic P Lemaigre; Kathryn M Stowell; Duncan T Odom; Paul Flicek; Merlin Crossley
Journal:  Am J Hum Genet       Date:  2013-03-07       Impact factor: 11.025

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.